Abstract

HAND proteins are tissue-restricted members of the basic helix-loop-helix transcription factor family that play critical roles in cell differentiation and organogenesis including placental, cardiovascular, and craniofacial development. Nevertheless, the molecular basis underlying the developmental action of HAND proteins remains undefined. Within the embryo, HAND1 is first detected in the developing heart where it becomes restricted to the atrial and left ventricular compartments, a pattern identical to that of the Nppa gene, which encodes atrial natriuretic factor, the major secretory product of the heart. We hereby report that the cardiac atrial natriuretic factor promoter is directly activated by HAND1, making it the first known HAND1 transcriptional target. The action of HAND1 does not require heterodimerization with class I basic helix-loop-helix factors or DNA binding through E-box elements. Instead, HAND1 is recruited to the promoter via physical interaction with MEF2 proteins. MEF2/HAND1 interaction results in synergistic activation of MEF2-dependent promoters, and MEF2 binding sites are sufficient to mediate this synergy. MEF2 binding to DNA is not enhanced in the presence of HAND1. Instead, cooperativity likely results from corecruitment of co-activators such as CREB-binding protein. The related HAND2 protein can also synergize with MEF2. Thus, HAND proteins act as cell-specific developmental co-activators of the MEF2 family of transcription factors. These findings identify a novel mechanism for HAND action in the heart and provide a general paradigm to understand the mechanism of HAND action in organogenesis.

Highlights

  • Required for proper cardiac cell differentiation and heart morphogenesis (6 –10)

  • The related HAND2 protein did not significantly activate the atrial natriuretic factor (ANF) promoter, a finding consistent with previous studies [23, 26] (Fig. 1A). These results indicate that the ANF promoter is responsive to HAND1 and provides a tool to elucidate the mechanisms of action of HAND1

  • We provide evidence that the ANF promoter is a downstream target for HAND1

Read more

Summary

Introduction

Required for proper cardiac cell differentiation and heart morphogenesis (6 –10). Targeted inactivation of hand leads to embryonic lethality around embryonic day 10.5 because of cardiovascular defects that include right ventricular hypoplasia and vascular abnormalities [8, 11]. All E-boxes were dispensable for HAND2/E12 action, which apparently required the Nkx2.5 binding site This was suggested to be relevant for ANF regulation in the right ventricular compartment [26]. In addition to their overlapping expression pattern, two recent studies suggest that ANF may be a transcriptional target for HAND1. The studies unravel a novel mechanism for HAND action, which involves direct physical association and cooperative interaction with MEF2 proteins These findings have broad implications for understanding the molecular mechanisms underlying HAND functions in cardiac and non-cardiac cells

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call